Invention Grant
US08148427B2 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
有权
苄胺衍生物或其药学上可接受的酸加成盐及其用于医疗目的的用途
- Patent Title: Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
- Patent Title (中): 苄胺衍生物或其药学上可接受的酸加成盐及其用于医疗目的的用途
-
Application No.: US12525364Application Date: 2008-01-31
-
Publication No.: US08148427B2Publication Date: 2012-04-03
- Inventor: Ryoji Hayashi , Tsukasa Kikuchi , Masaki Arai , Satoshi Kurosawa , Ko Hasebe , Sayoko Kanie , Seiichiro Ozono , Atsushi Otsuka
- Applicant: Ryoji Hayashi , Tsukasa Kikuchi , Masaki Arai , Satoshi Kurosawa , Ko Hasebe , Sayoko Kanie , Seiichiro Ozono , Atsushi Otsuka
- Applicant Address: JP
- Assignee: Toray Industries, Inc.
- Current Assignee: Toray Industries, Inc.
- Current Assignee Address: JP
- Agency: DLA Piper LLP (US)
- Priority: JP2007-020582 20070131
- International Application: PCT/JP2008/051479 WO 20080131
- International Announcement: WO2008/093767 WO 20080807
- Main IPC: A61K31/18
- IPC: A61K31/18 ; C07C307/00 ; A61P13/00
Abstract:
The benzylamine derivative represented by the formula below and a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical containing the derivative or the pharmaceutically acceptable acid addition salt thereof, and a therapeutic or prophylactic agent for pollakiuria or urinary incontinence containing the derivative or the pharmaceutically acceptable acid addition salt thereof are provided. The benzylamine derivative of the present invention and the pharmaceutically acceptable acid addition salt thereof have less possibility of occurrence of side effects than known compounds, and show a better therapeutic effect against pollakiuria or urinary incontinence, so that they can be used as excellent therapeutic or prophylactic agents for pollakiuria or urinary incontinence.
Public/Granted literature
Information query
